GSK prices $6.50B multi-tranche notes offering in SEC filing
GSK priced a $6.50 billion multi-tranche notes offering, disclosed via an SEC filing.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.